logo

La Jolla Pharmaceutical Co (LJPC)



Trade LJPC now with
  Date
  Headline
2/12/2018 6:33:27 AM Jefferies Is Cutting La Jolla Pharmaceutical Co (LJPC) FY19 Rev. Estimate To 44.3 M From 54.1 M
2/12/2018 6:33:09 AM Jefferies Is Cutting La Jolla Pharmaceutical Co (LJPC) FY18 Rev. Estimate To 6.7 M From 52.9 M
2/12/2018 6:32:33 AM Jefferies Is Lowering La Jolla Pharmaceutical Co (LJPC) FY19 Estimate To -2.92 From -2.44
2/12/2018 6:32:13 AM Jefferies Is Lowering La Jolla Pharmaceutical Co (LJPC) FY18 Estimate To -4.28 From -2.38
2/12/2018 6:31:08 AM Jefferies Lowers La Jolla Pharmaceutical Co (LJPC) To Underperform From Buy With $29 Down From $40 Price Target
1/7/2018 9:50:22 AM New Drugs Approved In December
9/25/2017 6:35:50 AM La Jolla Pharma Announces Intent To Submit Marketing Authorization Application For LJPC-501 In Q3
8/28/2017 9:04:46 AM La Jolla Pharma Announces U.S. FDA Acceptance Of New Drug Application For LJPC-501
8/8/2017 9:04:34 AM La Jolla Pharmaceutical Reports Launch Of Expanded Access Program For LJPC-501
5/21/2017 3:10:26 PM Results Of ATHOS-3 Phase 3 Study Of LJPC-501 Published